DICERNA PHARMACEUTICALS INC's ticker is DRNA and the CUSIP is 253031108. A total of 177 filers reported holding DICERNA PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 3.06 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $10,429,000 | -44.1% | 517,263 | +3.5% | 0.00% | -50.0% |
| Q2 2021 | $18,658,000 | +35.0% | 499,923 | -7.5% | 0.01% | +20.0% |
| Q1 2021 | $13,818,000 | +20.7% | 540,369 | +4.0% | 0.01% | 0.0% |
| Q4 2020 | $11,445,000 | +24.9% | 519,507 | +2.0% | 0.01% | +25.0% |
| Q3 2020 | $9,162,000 | -24.0% | 509,238 | +7.3% | 0.00% | -33.3% |
| Q2 2020 | $12,057,000 | +85.2% | 474,672 | +34.0% | 0.01% | +50.0% |
| Q1 2020 | $6,509,000 | -8.5% | 354,276 | +9.7% | 0.00% | 0.0% |
| Q4 2019 | $7,114,000 | +42.0% | 322,895 | -7.4% | 0.00% | +33.3% |
| Q3 2019 | $5,010,000 | +5.2% | 348,825 | +15.4% | 0.00% | 0.0% |
| Q2 2019 | $4,762,000 | +8.2% | 302,337 | +0.6% | 0.00% | 0.0% |
| Q1 2019 | $4,402,000 | +45.5% | 300,456 | +6.2% | 0.00% | +50.0% |
| Q4 2018 | $3,025,000 | -13.8% | 282,967 | +23.1% | 0.00% | 0.0% |
| Q3 2018 | $3,509,000 | +219.9% | 229,930 | +156.9% | 0.00% | +100.0% |
| Q2 2018 | $1,097,000 | +837.6% | 89,500 | +310.3% | 0.00% | – |
| Q1 2016 | $117,000 | -54.8% | 21,814 | 0.0% | 0.00% | – |
| Q4 2015 | $259,000 | +43.9% | 21,814 | 0.0% | 0.00% | – |
| Q3 2015 | $180,000 | -41.0% | 21,814 | 0.0% | 0.00% | – |
| Q2 2015 | $305,000 | +28.2% | 21,814 | +107.2% | 0.00% | – |
| Q2 2014 | $238,000 | – | 10,528 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|